Revising US MMR Vaccine Recommendations Amid Changing Domestic Risks
This Viewpoint discusses updating the existing recommendation for an additional early MMR dose to infants aged 6 to 11 months traveling to any region with increased probability of measles exposure.
Authors
- Rochelle P. Walensky (ORCID: https://orcid.org/0000-0002-8795-379X)
- Benjamin M. Rader (ORCID: https://orcid.org/0000-0002-6095-0193)
- John S. Brownstein (ORCID: https://orcid.org/0000-0001-8568-5317)
- Wesley Rogers
Institutions
- Boston Children's Hospital (US)
- Harvard University (US)
- Internationale Akademie Berlin (DE)
- New York University (US)
- Bayer (Germany) (DE)
Publication Details
- Journal
- JAMA
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1001/jama.2025.3867
- Citations
- 8
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 17.34